XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a significant decline in short interest during the month of June. As of June 30th, there was short interest totaling 276 shares, a decline of 50.4% from the June 15th total of 556 shares. Based on an average daily volume of 3,957 shares, the days-to-cover ratio is currently 0.1 days.
XOMA Stock Performance
NASDAQ XOMAP opened at $24.98 on Friday. XOMA has a twelve month low of $24.93 and a twelve month high of $30.00. The stock has a fifty day simple moving average of $25.32 and a 200 day simple moving average of $25.86.
XOMA Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, July 14th. Shareholders of record on Thursday, July 2nd were issued a dividend of $0.5391 per share. The ex-dividend date of this dividend was Thursday, July 2nd. This represents a $2.16 annualized dividend and a yield of 8.6%.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Stories
- Five stocks we like better than XOMA
- J.B. Hunt Stock Could Reach $340 as Trucking Capacity Shrinks
- The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
